MAPP BIOPHARMACEUTICAL
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. The company has been developing an Ebola therapy for more than a decade and has been working with the United States and Canadian governments to develop this therapy. Mapp Biopharmaceutical was founded in 2003 by Kevin Whaley and Larry Zeitlin. It is headquartered in San Diego, C.A.
MAPP BIOPHARMACEUTICAL
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.mappbio.com
Total Employee:
11+
Status:
Active
Contact:
(858) 625-0335
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Collaborations Pharma
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
IASO Pharma
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases.
PharmAkea Therapeutics
PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.
Qpex Biopharma
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Mapp Biopharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-09 | The University of Texas Medical Branch | Mapp Biopharmaceutical investment in Grant - The University of Texas Medical Branch | 35 M USD |
Official Site Inspections
http://www.mappbio.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
- Host name: cloudproxy10157.sucuri.net
- IP address: 192.124.249.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
